These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38262421)

  • 1. Subjective Smell Disturbances in Children with Sars-Cov-2 or Other Viral Infections do not Correspond with Olfactory Test Results.
    Grote H; Hoffmann A; Kerzel S; Lukasik H; Maier C; Mallon C; Schlegtendal A; Schwarzbach M; van Ackeren K; Volkenstein S; Brinkmann F
    Klin Padiatr; 2024 Feb; 236(2):129-138. PubMed ID: 38262421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smell Status in Children Infected with SARS-CoV-2.
    Rusetsky Y; Meytel I; Mokoyan Z; Fisenko A; Babayan A; Malyavina U
    Laryngoscope; 2021 Aug; 131(8):E2475-E2480. PubMed ID: 33443298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olfactory disorders in childhood: A comparative study of olfaction in children with adenoid hyperplasia versus a control group and the postoperative effects of adenoidectomy with respect to olfactory ability.
    Lukasik H; Grote H; Bogaert S; Volkenstein S; Schlegtendal A; Eitner L; Beermann L; Maier C; Brinkmann F; van Ackeren K
    Int J Pediatr Otorhinolaryngol; 2023 Nov; 174():111735. PubMed ID: 37801831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Objective Sensory Testing Methods Reveal a Higher Prevalence of Olfactory Loss in COVID-19-Positive Patients Compared to Subjective Methods: A Systematic Review and Meta-Analysis.
    Hannum ME; Ramirez VA; Lipson SJ; Herriman RD; Toskala AK; Lin C; Joseph PV; Reed DR
    Chem Senses; 2020 Dec; 45(9):865-874. PubMed ID: 33245136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural trajectory of recovery of COVID-19 associated olfactory loss.
    Khan AM; Lee J; Rammaha T; Gupta S; Smith H; Kannampallil T; Farrell N; Kallogjeri D; Piccirillo JF
    Am J Otolaryngol; 2022; 43(5):103572. PubMed ID: 35969913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smell loss associated with SARS-CoV-2 is not clinically different from other viruses: a multicenter cohort study.
    Miyake MM; Valera FCP; Martins RB; Compagnoni IM; Fantucci MZ; Murashima AAB; da Silva LECM; de Lima TM; de Souza MVO; Melo SR; Dolci RLL; Floriano CG; de Campos CAC; Nakanishi M; Freire GSM; Valente AL; Fornazieri MA; da Silva JLB; Anzolin LK; Issa MJA; Souza TV; Lima BA; SantAnna GD; Abreu CB; Sakano E; Cassettari AJ; Avelino MAG; Goncalves MC; de Camargo LA; Romano FR; Alves RD; Roithmann R; Redeker NK; Filho LLB; Dassi CS; Meurer ATO; Garcia DM; Aragon DC; Tepedino MS; Succar ACS; Vianna PM; Dos Santos MCJ; Filho RHR; Kosugi EM; Villa JF; Gregorio LL; Piltcher OB; Meotti CD; Tamashiro E; Arruda E; Anselmo Lima WT
    Rhinology; 2024 Feb; 62(1):55-62. PubMed ID: 37772802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Post-Infectious Anosmia and Hyposmia: A Systematic Review.
    Nag AK; Saltagi AK; Saltagi MZ; Wu AW; Higgins TS; Knisely A; Ting JY; Illing EA
    Ann Otol Rhinol Laryngol; 2023 Jul; 132(7):806-817. PubMed ID: 35959948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-lasting olfactory dysfunction in COVID-19 patients.
    Prem B; Liu DT; Besser G; Sharma G; Dultinger LE; Hofer SV; Matiasczyk MM; Renner B; Mueller CA
    Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3485-3492. PubMed ID: 34757458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The course of subjective and objective chemosensory dysfunction in hospitalized patients with COVID-19: a 6-month follow-up.
    Bertlich M; Stihl C; Lüsebrink E; Hellmuth JC; Scherer C; Freytag S; Spiegel JL; Stoycheva I; Canis M; Weiss BG; Ihler F; Haubner F
    Eur Arch Otorhinolaryngol; 2021 Dec; 278(12):4855-4861. PubMed ID: 33837835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olfactory function and viral recovery in COVID-19.
    Mazzoli M; Molinari MA; Tondelli M; Giovannini G; Ricceri R; Ciolli L; Picchetto L; Meletti S
    Brain Behav; 2021 Mar; 11(3):e02006. PubMed ID: 33465295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of anosmia/hyposmia in post-COVID-19 patients: a cross-sectional study in an eastern province of Saudi Arabia.
    Mohamed R; Alsuhibani R; Almasaoud H; Alsubhi S; Alabdulazeem L; Alzahrani N; Alsaif S; Al Ghamdi K; Al-Asoom L
    Acta Biomed; 2023 Dec; 94(6):e2023259. PubMed ID: 38054673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of subjective and tested olfactory dysfunction as a screening tool for COVID-19 in children.
    Danielsen LMA; Fjældstad AW; Ovesen T
    Dan Med J; 2023 Apr; 70(5):. PubMed ID: 37125823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson's disease (PD) do not overlap.
    Morbelli S; Chiola S; Donegani MI; Arnaldi D; Pardini M; Mancini R; Lanfranchi F; D'amico F; Bauckneht M; Miceli A; Biassoni E; Orso B; Barisione E; Benedetti L; Gianmario S; Nobili F
    Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1939-1950. PubMed ID: 34984501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Importance of Considering Olfactory Dysfunction During the COVID-19 Pandemic and in Clinical Practice.
    Desai M; Oppenheimer J
    J Allergy Clin Immunol Pract; 2021 Jan; 9(1):7-12. PubMed ID: 33130145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Loss of smell, a preliminary indicator of COVID-19].
    Waizel-Haiat S; Waizel-Bucay J
    Rev Med Inst Mex Seguro Soc; 2021 Feb; 59(1):4-6. PubMed ID: 33666408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olfactory Dysfunction in COVID-19 Patients: Prevalence and Prognosis for Recovering Sense of Smell.
    D'Ascanio L; Pandolfini M; Cingolani C; Latini G; Gradoni P; Capalbo M; Frausini G; Maranzano M; Brenner MJ; Di Stadio A
    Otolaryngol Head Neck Surg; 2021 Jan; 164(1):82-86. PubMed ID: 32662745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive Olfactory Training in Post-COVID-19 Patients: A Multicenter Randomized Clinical Trial.
    Pires ÍAT; Steffens ST; Mocelin AG; Shibukawa DE; Leahy L; Saito FL; Amadeu NT; Lopes NMD; Garcia ECD; Albanese ML; De Mari LF; Ferreira IM; Veiga CA; Jebahi Y; Coifman H; Fornazieri MA; Hamerschmidt R
    Am J Rhinol Allergy; 2022 Nov; 36(6):780-787. PubMed ID: 35866202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olfactory dysfunction in SARS-CoV-2 infection: Focus on odorant specificity and chronic persistence.
    Rebholz H; Pfaffeneder-Mantai F; Knoll W; Hassel AW; Frank W; Kleber C
    Am J Otolaryngol; 2021; 42(5):103014. PubMed ID: 33873048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proof-of-concept: SCENTinel 1.1 rapidly discriminates COVID-19-related olfactory disorders.
    Hunter SR; Hannum ME; Pellegrino R; O'Leary MA; Rawson NE; Reed DR; Dalton PH; Parma V
    Chem Senses; 2023 Jan; 48():. PubMed ID: 36796784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing olfactory dysfunction in acute and recovered COVID-19 patients: a single center study in Italy.
    Pasquini J; Maremmani C; Salvadori S; Silani V; Ticozzi N
    Neurol Sci; 2021 Jun; 42(6):2183-2189. PubMed ID: 33768438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.